dicerna.comCrawled Oct 16, 2026
The page covers type 1 and type 2 diabetes and Novo Nordisk's efforts to develop treatments.
Information for US health care professionals on Novo Nordisk Products and Resources.
The page covers hemophilia and rare bleeding disorders and Novo Nordisk's work to advance treatments for them.
Stacey shares how her diabetes diagnosis led to positive changes for her family.
Hear from Novo Nordisk employee Sebastian Parlee, a member of the LGBTQ2+ community, about how he went from seeking community to helping build it.
Novo Nordisk U.S. describes its response to racial injustice and steps employees are taking to make progress.
Find archived news and media from Novo Nordisk U.S.
The Novo Nordisk Way supports a culture of innovation and responsibility at Novo.
Notice on fraudulent job offers
The page provides information about career programs and an event calendar for upcoming career fairs and events.
The page describes career areas at Novo Nordisk, including research and development, manufacturing, marketing, and sales, and includes FAQs.
Novo Nordisk strives to support a healthcare system that ensures access and affordability for patients with diabetes and other serious chronic diseases.
The page features Anna Frable, vice president of communications for Novo Nordisk Inc.
The page features Colleen Silk, corporate vice president of rare disease at Novo Nordisk Inc.
The page features Daniel Muusmann Bohsen, senior vice president of finance and operations at Novo Nordisk Inc.
The page features Ed Cinca, senior vice president of marketing & patient solutions.
Novo Nordisk considers expanded access programs case by case for patients with serious conditions who meet certain criteria.
The page provides Trade Business Partners with information about the company's efforts to improve and streamline.
Novo Nordisk U.S. supports scientific and humanitarian causes and provides information on applying for grants and its programs.
Novo says it is helping to address diabetes, rare bleeding disorders, growth hormone-related disorders, and obesity in the U.S.
